Accella Advisors


Project: Market Entry Study

       The problem
A Japanese pharmaceutical company wanted to evaluate the market opportunity for a cardiovascular product in Europe.

The solution
A panel of opinion leaders in the field was assembled. They were asked in a structured process to give their advice about the mechanism of the product and its usefulness in medical practice. A comprehensive report was presented to the company.

The outcome
It appeared that the product profile was not suitable for the European market, resulting in a small commercial potential.
The company decided not to develop and launch the product in Europe.

Reference project: Company Due Diligence